The increasing prevalence of metabolic syndrome and obesity has led to a global rise in non-alcoholic fatty liver disease (NAFLD) and advanced hepatic fibrosis (AHF), both of which have become major public health issues. Nutritional indices such as GNRI, PNI, CONUT, TCBI and AGR are widely used in clinical practice to evaluate nutritional status and prognosis, particularly in patients with cancer, cardiovascular diseases, and other severe conditions. Despite their clinical utility, our study is the first to comprehensively analyze the association between these five nutritional markers and NAFLD/AHF.Using data from 5,514 participants collected from the NHANES database between 2017 and March 2020, our retrospective analysis demonstrated that malnutrition is significantly associated with the incidence of both NAFLD and AHF after adjusting for all potential confounding factors. Specifically, GNRI, PNI, and TCBI showed positive associations with NAFLD, whereas CONUT and AGR exhibited negative associations. Furthermore, GNRI, CONUT, and TCBI were positively linked to AHF, while AGR was negatively correlated with AHF.
The GNRI combines serum albumin levels and body weight data to assess the prognosis of patients with various diseases. Zhao et al. 12 analyzed 12,058 patients with acute kidney injury (AKI) from the eICU Collaborative Research Database and found that a nutritional risk (GNRI < 98) was significantly associated with increased in-hospital mortality among AKI patients in the intensive care unit. Another cohort study from China demonstrated that GNRI was negatively correlated with the risk of all-cause mortality in patients with atrial fibrillation, and that a higher GNRI acted as a protective factor in this population. Our study found that GNRI was positively correlated with the risk of NAFLD and AHF. This may be due to GNRI being composed of two components: serum albumin and current body weight/standard body weight. Albumin, one of the primary plasma proteins in the human body, plays a crucial role in maintaining plasma colloid osmotic pressure and transporting endogenous and exogenous substances 13. Recent studies indicate that a reduction in albumin levels is closely related to the progression of NAFLD. In patients with NAFLD, low albumin levels are often associated with aggravated liver fibrosis, likely due to chronic inflammation, oxidative stress, and diminished albumin synthesis resulting from liver dysfunction 14. In patients with AHF, hypoalbuminemia is more pronounced, reflecting severe impairment of liver synthetic function and closely correlating with further disease progression and an adverse prognosis. A study by Khanna et al. 15demonstrated that a sustained reduction in albumin levels may predict liver failure and an increased incidence of complications, including ascites, hepatic encephalopathy, and infection. In contrast to the protective effect of albumin, obesity is a major risk factor for the development of NAFLD and AHF. Kuang et al. demonstrated that obesity-related indices such as BMI, A Body Shape Index (ABSI), Anthropometric Risk Index (ARI), and waist circumference were significantly and positively correlated with the risk of NAFLD. Obesity is associated with lipid metabolism disorders and excessive fat accumulation in the liver. This steatosis induces liver cell stress, oxidative damage, and non-alcoholic steatohepatitis (NASH), ultimately resulting in liver cell damage and the initiation of fibrosis 16. Lipid metabolism disorders and chronic low-grade inflammation promote abnormal liver collagen deposition and accelerate fibrosis formation 17. Additionally, obesity is closely linked to metabolic syndrome (e.g., insulin resistance, hypertension, and dyslipidemia), which is a key risk factor for the progression of NAFLD to AHF 18.
The PNI comprises serum albumin levels and lymphocyte counts and is used to predict the risk of malnutrition and postoperative complications. It is widely used in assessing the survival prognosis of cancer patients. A PNI value below 40 typically indicates poor nutritional status. Pinato et al. 19analyzed clinical data from 112 liver cancer patients and found that PNI is an independent predictor of poor prognosis. Another cohort study demonstrated that PNI is an important predictor of recurrence and survival after radical surgery for early-stage hepatocellular carcinoma 20. The pathogenesis of NAFLD involves complex metabolic disorders and chronic low-grade inflammation, where lymphocytes play a dual role. Activated T lymphocytes, such as helper T cells 1 (Th1) and 17 (Th17), secrete pro-inflammatory cytokines like interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), exacerbating liver cell damage and apoptosis, stimulating hepatic stellate cell activation, and leading to excessive collagen deposition 21. Conversely, regulatory T cells (Treg) and helper T cells 22 (Th22) inhibit excessive immune responses by secreting anti-inflammatory cytokines (IL-10, IL-22), thereby reducing liver damage and exerting an anti-fibrosis effect 22. Additionally, IgG autoantibodies produced by B lymphocytes can accelerate the progression of NAFLD fibrosis. As NAFLD progresses to advanced liver fibrosis, lymphocytes increasingly promote fibrosis 23. Our study found that PNI was significantly positively correlated with the risk of NAFLD, while no significant association was found with AHF. A retrospective study from the same NHANES cohort showed that an increase in PNI was positively correlated with an increased risk of NAFLD and negatively correlated with an increased risk of AHF. This may be attributed to differing inclusion and exclusion criteria for the samples and varying covariates 11.
The CONUT score comprises serum albumin, total lymphocyte count, and total cholesterol scores, which collectively assess the patient’s protein-energy malnutrition and immune function status. Low serum albumin levels reflect decreased liver function and impaired protein synthesis. The total lymphocyte count is a key indicator of immune system function, reflecting the patient’s current immune response capacity. Total cholesterol levels are closely linked to energy metabolism and nutritional status, with lower cholesterol levels generally indicating malnutrition 24. Patients with NAFLD experience lipid metabolism disorders, characterized by elevated serum cholesterol levels that result in excessive cholesterol accumulation in hepatocytes. Excessive intrahepatic cholesterol induces mitochondrial damage and oxidative stress, subsequently activating hepatic stellate cells (HSCs) and promoting liver fibrosis 25. In the early stages of the disease, elevated total cholesterol is closely associated with hepatic steatosis and inflammation. However, as the disease progresses to advanced liver fibrosis, liver synthetic function becomes impaired, and cholesterol synthesis and metabolism decline, potentially leading to lower serum total cholesterol levels 26. This dynamic shift in cholesterol levels reflects the pathophysiological progression of NAFLD to AHF. Our study found that the CONUT score was negatively correlated with the incidence of NAFLD and positively correlated with the incidence of AHF. A possible explanation is that in the early stages of NAFLD, patients are often overweight or obese, typically associated with better nutritional reserves and higher protein levels. As a result, despite the formation of fatty liver, the CONUT score remains low. However, as the disease progresses to advanced fibrosis, liver synthetic function becomes impaired, protein metabolism is disrupted, immune function declines, and cholesterol synthesis decreases, leading to an increase in the CONUT score. Miano et al. 27 found that an elevated CONUT score is closely associated with severe hepatic steatosis but not significantly correlated with moderate steatosis. Severe hepatic steatosis is often accompanied by significant liver fibrosis, supporting our findings to some extent.
TCBI is a novel and straightforward nutritional tool that evaluates a patient's nutritional and metabolic health status, primarily based on triglyceride levels, total cholesterol, and body weight. A retrospective observational cohort study from Japan demonstrated that a lower TCBI score was significantly associated with an increased risk of all-cause mortality, cardiovascular disease mortality, and cancer mortality 28. Another recent study found that TCBI was independently and negatively associated with stroke prevalence, particularly in hypertensive patients under 60 years of age 29. Our study found that TCBI was significantly positively correlated with the risk of NAFLD and AHF, likely due to the combined effects of triglycerides, total cholesterol, and body weight. Triglycerides are the primary form of fat storage in the liver. Elevated serum triglyceride levels typically reflect abnormal fat metabolism, and excessive fat accumulation in the liver contributes to the development of NAFLD. Insulin resistance is a core pathological mechanism of NAFLD. Insulin resistance decreases the liver's sensitivity to insulin, leading to increased fatty acid mobilization and enhanced triglyceride synthesis, which further promotes intrahepatic fat accumulation 30. Additionally, excessive triglycerides activate immune cells, such as Kupffer cells, which release inflammatory factors like TNF-α and IL-1β, promoting the progression of NAFLD to AHF 31.
AGR is the ratio of serum albumin to globulin and reflects both liver function and the systemic inflammatory state. A low AGR typically indicates chronic inflammation, impaired liver function, or protein malnutrition, all of which are risk factors for poor prognosis. Wen et al. 32 demonstrated that in diabetic patients, higher serum AGR levels were significantly and linearly associated with reduced mortality from all causes, cancer, and cardiovascular diseases. Albumin, produced by the liver, has antioxidant, anti-inflammatory, and immune-modulating functions. Higher albumin levels are typically associated with better liver function and overall health 33. Impaired liver function in NAFLD patients can lead to decreased albumin production and reduced serum albumin levels. Globulin plays a key role in the immune response and is a potential predictor of inflammation and cancer 34. NAFLD development is often accompanied by chronic inflammation and immune system activation, prompting the body to produce more immunoglobulins 35. As liver fibrosis progresses and liver cell function further deteriorates, immune and inflammatory responses become more pronounced, causing globulin levels to rise. AGR is typically low when albumin levels are low and globulin levels are high. The protective effect of albumin diminishes, while the pathological increase in globulin reflects chronic inflammation and poor liver function. Our results indicate that AGR is negatively correlated with the risk of NAFLD and AHF.
Nutritional indicators such as GNRI, PNI, CONUT, TCBI, and AGR can reflect an individual's current nutritional status to a certain extent. Previous studies have typically identified nutrition as a protective factor against disease, with high nutritional status often indicating a lower disease prevalence and longer survival. Our study demonstrates that the relationship between nutritional status and NAFLD and AHF is complex. On the one hand, high nutritional status can lead to excessive fat accumulation in the liver, causing fat degeneration and inflammation, potentially increasing the risk of NAFLD. Persistent inflammatory stimuli and nutritional metabolites, such as cholesterol, exacerbate the progression of NAFLD to AHF. Conversely, nutrients like albumin can protect the liver through anti-inflammatory and antioxidant effects, improve the liver microenvironment, and delay disease progression. When liver cirrhosis progresses to liver failure, better nutritional status can enhance patient survival 36. Therefore, maintaining a proper balance of nutrient intake, reducing excessive calories and fat, and limiting sugars and simple carbohydrates can help control body weight and improve insulin resistance. Additionally, increasing the intake of high-quality protein can aid in repairing damaged liver cells and promote liver function recovery. Overall, an individualized nutritional intervention strategy is crucial for the prevention and management of NAFLD and AHF, and warrants clinical attention.
This study has several strengths. By utilizing all available continuous NHANES data cycles, it includes a large, nationally representative sample from across the United States, thereby enhancing the robustness of the statistical analysis and improving the generalizability of the findings. The study design accounted for a wide range of potential confounding factors, such as sociodemographic characteristics, lifestyle habits, health status, and laboratory parameters, with adjustments made through multivariate analysis to ensure accuracy and reliability. Importantly, this is the first comprehensive study to examine the association between nutritional indices and the risk of NAFLD and AHF, providing new insights into the potential role of nutritional status in these conditions. These findings contribute to more precise identification of high-risk populations and support the development of personalized intervention strategies.
This study has certain limitations. First, its cross-sectional design prevents the establishment of a causal relationship between nutritional status and the risk of NAFLD and AHF. Second, although numerous confounding factors were adjusted for, some external variables may not have been fully accounted for, potentially affecting the accuracy of the results. Furthermore, as the study is based on a representative sample from the United States, the generalizability of the findings to other populations may be limited. Therefore, further research and additional data are required to more thoroughly explore the relationship between nutritional status and NAFLD/AHF.